Results 201 to 210 of about 41,433 (269)
Some of the next articles are maybe not open access.

The Efficacy of Metoclopramide for Gastric Visualization by Endoscopy in Patients With Active Upper Gastrointestinal Bleeding: Double-Blind Randomized Controlled Trial

American Journal of Gastroenterology, 2023
INTRODUCTION: The 2021 American College of Gastroenterology Guidelines suggested using of intravenous erythromycin before endoscopy in patients with upper gastrointestinal bleeding (UGIB) to enhance endoscopic view and reduce the need for repeat ...
Thanrada Vimonsuntirungsri   +4 more
semanticscholar   +1 more source

Efficacy and Safety of Domperidone and Metoclopramide in Breastfeeding: A Systematic Review and Meta-Analysis

Breastfeeding Medicine, 2021
Objectives: To evaluate the efficacy and safety of domperidone and metoclopramide used by breastfeeding women. Methods: A systematic literature search retrieved citations from PubMed, Embase, The Cochrane Library, Medline, EBSCO, Web of Science ...
Quan Shen   +4 more
semanticscholar   +1 more source

Olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy–induced vomiting in children: An open‐label, randomized phase 3 trial

Pediatric Blood & Cancer, 2020
Breakthrough chemotherapy–induced vomiting (CIV) is defined as CIV occurring after adequate antiemetic prophylaxis. Olanzapine and metoclopramide are two drugs recommended for the treatment of breakthrough CIV in children, without adequate evidence.
V. Radhakrishnan   +11 more
semanticscholar   +1 more source

Intranasal Metoclopramide

Drugs, 1999
Intranasal metoclopramide is a new formulation of an established and effective antiemetic drug. Absorption after intranasal administration was lower than after oral or intravenous administration; otherwise the pharmacodynamic and pharmacokinetic profiles of the intranasal and parenteral formulations were similar.
D, Ormrod, K L, Goa
openaire   +2 more sources

Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited

Neurogastroenterology and Motility, 2019
Metoclopramide is primarily a dopamine receptor antagonist, with 5HT3 receptor antagonist and 5HT4 receptor agonist activity, and used as an antiemetic and gastroprokinetic since almost 50 years.
A. Al-Saffar   +2 more
semanticscholar   +1 more source

Metoclopramide for the treatment of diabetic gastroparesis

Expert Review of Gastroenterology & Hepatology, 2019
Introduction: Gastroparesis is a chronic disorder of the stomach characterized by delayed gastric emptying without mechanical obstruction. Diabetes is the most commonly known cause of gastroparesis. Management of diabetic gastroparesis involves lifestyle
M. Shakhatreh   +3 more
semanticscholar   +1 more source

METoclopramide Administration as a Strategy to Overcome MORPHine-ticagrelOr Interaction in PatientS with Unstable Angina PectorIS—The METAMORPHOSIS Trial

Thrombosis and Haemostasis, 2018
Extensive search for methods of overcoming morphine-related delay of the absorption and onset of action of oral P2Y12 inhibitors in patients presenting with acute coronary syndrome is on-going.
J. Sikora   +12 more
semanticscholar   +1 more source

Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide

Archives of pharmacal research, 2020
J. Bae   +11 more
semanticscholar   +1 more source

Metoclopramide

Medical Journal of Australia, 1986
Kerrie Brady   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy